Alpha-1-antitrypsin deficiency is associated with type 2 diabetes [71], and therapy with alpha-1-antitrypsin is already being tested as a treatment strategy for type 1 diabetes [72]. The gene discussed is SERPINA1; the disease is type 1 diabetes mellitus.